1. Home
  2. CMTV vs CGEN Comparison

CMTV vs CGEN Comparison

Compare CMTV & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CMTV

Community Bancorp. (VT)

N/A

Current Price

$38.08

Market Cap

226.5M

Sector

N/A

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.83

Market Cap

270.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTV
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
134
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
226.5M
270.4M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
CMTV
CGEN
Price
$38.08
$2.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
13.5K
577.7K
Earning Date
N/A
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.53
$1.30
52 Week High
$42.92
$3.24

Technical Indicators

Market Signals
Indicator
CMTV
CGEN
Relative Strength Index (RSI) 55.79 53.25
Support Level $37.29 $1.46
Resistance Level $42.86 $3.14
Average True Range (ATR) 1.65 0.18
MACD -0.15 -0.03
Stochastic Oscillator 49.96 54.37

Price Performance

Historical Comparison
CMTV
CGEN

About CMTV Community Bancorp. (VT)

Community Bancorp Inc is a holding company that provides a complete line of personal and business banking services with personal services and solutions. The company mainly offers Business banking, Commercial real estate lending, residential real estate lending, Retail credit, Municipal and Institutional Banking, and Retail Banking. The company's primary lending products are commercial, real estate, municipal, and consumer loans. The bank offers a complete line of personal and business products and services, along with offerings for non-profit organizations, municipalities, and local governments. The Firm also engages in lending activity outside the area of its branch network, through loan production offices in Burlington, Vermont, and Lebanon, New Hampshire.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: